Etrolizumab (RG7413) - IBD News Today
Etrolizumab (RG7413) is a monoclonal antibody, now in Phase 3 tests, being developed by Genentech to treat both ulcerative colitis and Crohn’s disease.
Source: ibdnewstoday.com
📰 Retro Studies News
Retro Studies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Retro Studies. Real-time updates on events, politics, business and more.